PURPOSE: To assess the approach of specialists to ocular tuberculosis (TB). METHODS: The American Uveitis Society (AUS) Listserv was surveyed using two clinical cases and general questions. RESULTS: Of 196 members, 87 responded (44.4%), of whom 64 were affiliated with practices in North America, while 23 were outside of North America. The survey provided normative data on how physicians evaluate patients with uveitis as well as opinions about ocular TB. Responses varied widely on such issues as (1) the pretest probability that a patient with granulomatous panuveitis had TB uveitis (range 1-75%) or that a patient with a risk factor for TB had ocular TB (range 0-90%); (2) the optimal duration of anti-TB therapy; and (3) whether therapy should be discontinued after 2 months in nonresponders. CONCLUSIONS: Consensus is lacking among uveitis specialists for the diagnosis or management of ocular TB.
PURPOSE: To assess the approach of specialists to ocular tuberculosis (TB). METHODS: The American Uveitis Society (AUS) Listserv was surveyed using two clinical cases and general questions. RESULTS: Of 196 members, 87 responded (44.4%), of whom 64 were affiliated with practices in North America, while 23 were outside of North America. The survey provided normative data on how physicians evaluate patients with uveitis as well as opinions about ocular TB. Responses varied widely on such issues as (1) the pretest probability that a patient with granulomatous panuveitis had TB uveitis (range 1-75%) or that a patient with a risk factor for TB had ocular TB (range 0-90%); (2) the optimal duration of anti-TB therapy; and (3) whether therapy should be discontinued after 2 months in nonresponders. CONCLUSIONS: Consensus is lacking among uveitis specialists for the diagnosis or management of ocular TB.
Authors: Luis Anibarro; Eliana Cortés; Ana Chouza; Alberto Parafita-Fernández; Juan Carlos García; Alberto Pena; Carlos Fernández-Cid; África González-Fernández Journal: Infection Date: 2018-06-04 Impact factor: 3.553
Authors: David R Brunner; Sandrine A Zweifel; Daniel Barthelmes; Fabio Meier; Christian Böni Journal: Int Ophthalmol Date: 2017-10-13 Impact factor: 2.031
Authors: Erika Marie Damato; Sarah Dawson; Xiaoxuan Liu; Chandoshi Mukherjee; John Horsburgh; Alastair K Denniston; Edward Moran; Martin Dedicoat; Philip Ian Murray Journal: J Ophthalmic Inflamm Infect Date: 2017-12-04
Authors: Onn Min Kon; Nicholas Beare; David Connell; Erika Damato; Thomas Gorsuch; Guy Hagan; Felicity Perrin; Harry Petrushkin; Jessica Potter; Charanjit Sethi; Miles Stanford Journal: BMJ Open Respir Res Date: 2022-03
Authors: M Shahidatul-Adha; E Zunaina; A T Liza-Sharmini; W H Wan-Hazabbah; I Shatriah; I Mohtar; Y Azhany; H Adil Journal: Ann Med Surg (Lond) Date: 2017-10-13
Authors: M La Cava; A Bruscolini; M Sacchetti; M P Pirraglia; A Moramarco; M Marenco; G Iaiani; G Covelli; T Rizzo; I Abicca; A Lambiase Journal: J Ophthalmol Date: 2020-03-14 Impact factor: 1.909